Dr. Chirantan Bose is a distinguished leader in precision oncology, recognized for his unique blend of expertise in molecular oncology, clinical genetics, pathology, diagnostics management, and healthcare leadership. With more than two decades of experience in molecular medicine and cancer diagnostics, he currently serves as the Head of the Department of Molecular and Precision Oncology at Mumbai Oncocare Centre (MOC), one of India’s leading medical oncology networks. Throughout his career, Dr. Bose has played a pivotal role in integrating advanced cancer genomics into personalized oncology practice. He has led groundbreaking research in liquid biopsy, with a particular focus on circulating tumor cells (CTCs), contributing to advancements in early cancer detection, real-time monitoring of disease progression, and precision treatment planning. His research collaborations extend across globally renowned cancer centers and scientific groups in Asia, the USA, Canada, Australia, Africa, and the GCC. Beyond research, Dr. Bose is a seasoned strategist and thought leader in the medical diagnostics ecosystem. He has successfully established, scaled, and managed cutting-edge precision oncology and pathology services, driving innovation in laboratory operations and clinical workflows. His leadership spans medical governance, quality assurance, clinician partnerships, business development, and revenue cycle management. He is widely respected for building diagnostic systems that are patient-centric, data-driven, technologically advanced, and cost-efficient. A strong advocate for the future of personalized medicine, Dr. Bose continues to influence clinical practice, contribute to translational research, and mentor professionals across the oncology and diagnostic domains. His work embodies a commitment to improving cancer care outcomes through innovation, precision, and compassionate leadership.